IBB0979

· SUNHO（China）BioPharmaceutical CO., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IBB0979, covering 2025-01-17 to 2025-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer [Phase 2]

See pricing